Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

NCT00835549 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Cefdinir for oral suspension 250 mg/5mL
DRUG: OMNICEF® for oral suspension 250 mg/5mL

Sponsor

Teva Pharmaceuticals USA